🇺🇸 FDA
Patent

US 8142787

Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

granted A61PA61P31/04A61P33/02

Quick answer

US patent 8142787 (Recombinant chimeric antigens for diagnosis and prevention of scrub typhus) held by United States of America as represented by the Secretary of the Air Force expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P31/04, A61P33/02, A61P37/04